every patient is unique, their cancer treatment should be too
Kallisio creates personalized precision solutions for oncology.
Stentra™ — our first FDA and CE cleared device — is available now.
one size does
not fit all
when treatment isn’t built for the individual, patients pay the price
Generic, one-size-fits-all medical devices can’t account for each patient’s individual anatomy. The result: less precise treatment, avoidable side effects, and outcomes that fall short of what’s possible.
In head and neck cancer radiation therapy, for example, the consequences are well documented: painful mouth sores (mucositis), difficulty swallowing,treatment interruptions.
precision care built around the individual, not the average patient
At Kallisio, every solution we develop starts with the same principle – that effective treatment means accounting for each patient’s unique anatomy, not defaulting to one-size-fits-all. We’re building a pipeline of patient-specific solutions across oncology, each designed to reduce avoidable harm and improve outcomes.
Stentra is our first solution, and it’s already changing outcomes in head and neck radiation therapy.
Flagship product
Stentra™ custom 3D-printed immobilization device for a sub-millimeter precision fit
easily integrate precision into your treatment workflow
Capture your patient data
Step 1
1
Receive your patient-specific solution
Step 2
2
Treat your patient
Step 3
3
scalable innovation, one
patient at a time
gain up to 2–3 hours* per patient in workflow efficiency
The Stentra System improves efficiency by reducing simulation setup time and speeding up treatment planning. A patient-precision fit ensures easy reproducibility, minimizing delays and increasing accuracy.
*calculated from several clinical studies we can share
stentra is our first solution, it won't be our last
Kallisio is developing a pipeline of patient-specific oncology solutions each built on the same principle of precision personalized care. If you’re a clinician, partner, or investor interested in what’s coming next, we’d like to hear from you.
ready to bring precision care to your patients?
Join the cancer centres already using Stentra — Kallisio’s first FDA and CE cleared solution for head and neck radiation therapy. Our team will respond within 24 hours.
Contact Us
